Aptus Clinical helps transform promising drug projects into valued medicines. Our team of experts has decades of large pharma experience in designing, conducting and successfully delivering innovative early phase clinical studies, with a particular focus in oncology/immuno-oncology and rare diseases.
Aptus Clinical is proud to be part of the Manchester Advanced Therapy Centre Hub (iMATCH), which seeks to scale-up the development of cell/gene therapies in the UK.
- Design of innovative clinical studies to optimise clients’ clinical development plans
- Full service CRO delivery of early phase clinical studies.
- Identification, set-up and oversight of investigational sites
Please visit aptusclinical.com